- Trials with a EudraCT protocol (14)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
14 result(s) found for: Denervation.
Displaying page 1 of 1.
EudraCT Number: 2017-003117-25 | Sponsor Protocol Number: V3.0 | Start Date*: 2018-05-17 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Longitudinal chemodenervation effects of botulinum toxin A after intramuscular application and the impact of physical activity | ||
Medical condition: Spastic hemiparesis with involvement of the M. biceps brachii | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-006817-12 | Sponsor Protocol Number: 2031-38 | Start Date*: 2022-06-24 |
Sponsor Name:ASSITANCE PUBLIQUE HOPITAUX DE MARSEILLE | ||
Full Title: Evaluation of the efficacy of an intra-articular injection of autologous microfat combined with autologous platelet-enriched plasma in the treatment of radiocarpal osteoarthritis: a randomized cont... | ||
Medical condition: radiocarpal osteoarthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000036-96 | Sponsor Protocol Number: CR0014 | Start Date*: 2018-09-06 | |||||||||||
Sponsor Name:Ablative Solutions, Inc. | |||||||||||||
Full Title: A Phase 2, Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation by the Peregrine System Kit, in Subjects with Hypertension, in the Absence of Antihypertensive Medications | |||||||||||||
Medical condition: Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) GB (GB - no longer in EU/EEA) DE (Completed) IE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002545-32 | Sponsor Protocol Number: CR0002 | Start Date*: 2019-11-06 | |||||||||||
Sponsor Name:Ablative Solutions, Inc | |||||||||||||
Full Title: A Pivotal, Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation by the Peregrine System™ Kit, in Subjects with Hypertension. | |||||||||||||
Medical condition: Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) FR (Trial now transitioned) SE (Ongoing) BE (Trial now transitioned) NL (Trial now transitioned) IE (Trial now transitioned) PL (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-001066-14 | Sponsor Protocol Number: DENERVHTA | Start Date*: 2012-07-17 |
Sponsor Name:Consorci Mar Parc de salut de Barcelona ( Parc de Salut Mar) | ||
Full Title: Sympathetic renal denervation versus increment of pharmacological treatment in resistant arterial hypertension | ||
Medical condition: subjects with resistant hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-018226-29 | Sponsor Protocol Number: botox2010 | Start Date*: 2010-04-20 |
Sponsor Name: | ||
Full Title: The effect of botulinum toxin type A injections in the m. rectus femoris in stroke patients presenting with a stiff knee gait. | ||
Medical condition: Stroke patients with stiff knee gait. Stiff knee gait is characterized as a diminished knee flexion during swing phase of gait. It is common in stroke patients. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004995-13 | Sponsor Protocol Number: 38372 | Start Date*: 2012-02-09 | |||||||||||
Sponsor Name:Erasmus MC | |||||||||||||
Full Title: Endovascular renal sympathetic denervation versus spironolactone for treatment-resistant hypertension: a randomized, multicentric study | |||||||||||||
Medical condition: Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003014-22 | Sponsor Protocol Number: Thalamus_V3 | Start Date*: 2018-06-25 |
Sponsor Name:Medical University of Vienna | ||
Full Title: The role of leptin in regulating hepatic lipid metabolism in humans | ||
Medical condition: lipodystrophy patients, patients after liver transplantation and healthy controls | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-003915-11 | Sponsor Protocol Number: CarniValI (Uni-Koeln-1107) | Start Date*: 2009-09-24 | |||||||||||
Sponsor Name:University of Utah | |||||||||||||
Full Title: Phase I/II Trial of Valproic Acid and Carnitine in Infants with Spinal Muscular Atrophy Type I (CARNI-VAL Type I) | |||||||||||||
Medical condition: Spinal Muscular Atrophy Type I in infants | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004636-66 | Sponsor Protocol Number: KP-2011-0077 | Start Date*: 2011-12-05 |
Sponsor Name:Uppsala University Hospital | ||
Full Title: Single-blinded randomized trial of Botulinumtoxin A (Vistabel®) and its objective paralytic effect in the facial muscles of healthy women: development of new neurophysiological measurements. | ||
Medical condition: The treatment of glabellar lines in healthy women by muscle paralysis from injection of botulinum toxin | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002499-42 | Sponsor Protocol Number: Version1on02-02-2018 | Start Date*: 2018-08-29 |
Sponsor Name:Cliniques Universitaires Saint-Luc | ||
Full Title: Evaluation of the effect of repeated injections of high doses of botulinum toxin into the lower limb of spastic brain lesions on functional and biomechanical parameters of walking | ||
Medical condition: Patients with spastic brain lesions. Children with cerebral palsy (CP) and in the hemiplegic adult. | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-006614-37 | Sponsor Protocol Number: CryoStopPersAF | Start Date*: 2022-05-11 | |||||||||||
Sponsor Name:Region Örebro | |||||||||||||
Full Title: First-line cryoablation for early treatment of Persistent Atrial Fibrillation – a randomized study comparing early trigger isolation using the Cryoballoon versus antiarrhythmic medication. | |||||||||||||
Medical condition: Persistent symptomatic atrial fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012836-33 | Sponsor Protocol Number: KIP113049 | Start Date*: 2009-11-26 | |||||||||||
Sponsor Name:GlaxoSmithKline Research & Development Limited | |||||||||||||
Full Title: A randomised, double blind study to evaluate the safety and efficacy of the p38 kinase inhibitor, GW856553, in subjects with neuropathic pain from lumbosacral radiculopathy | |||||||||||||
Medical condition: Neuropathic pain from lumbosacral radiculopathy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) DE (Completed) DK (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-018157-23 | Sponsor Protocol Number: D0490C00014 | Start Date*: 2010-11-30 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Phase IIa, Multi-Centre, Double-Blind, Randomised, Placebo-Controlled, Parallel Group 12-Month Treatment, Adaptive Design Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics ... | |||||||||||||
Medical condition: Multiple system atrophy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) ES (Prematurely Ended) AT (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
